Company Name:NuCana plc
CEO: Hugh Griffith

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: NuCana PLC is a clinical-stage biopharmaceutical company. It is focused on improving treatment outcomes for cancer patients by applying its ProTide technology.


Key numbers

Market Capitalization:191416440
Shares Outstanding: 31956000
Float: 27963609.096
Next Earning Date:2020-03-18
TTm EPS: -0.6454
TTm Dividend Rate:
200 days moving average:10.88
50 days moving average: 7.11
One day percent Change: 2.74



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,